125 related articles for article (PubMed ID: 31595166)
1. Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis.
Liu W; Li W; Liu H; Yu X
Int J Biol Sci; 2019; 15(11):2497-2508. PubMed ID: 31595166
[TBL] [Abstract][Full Text] [Related]
2. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis.
Zheng M; Wu C; Yang K; Yang Y; Liu Y; Gao S; Wang Q; Li C; Chen L; Li H
Pharmacol Res; 2021 Feb; 164():105367. PubMed ID: 33307221
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol, a Prenylated Flavonoid from Hops, Induces DNA Damages in Colorectal Cancer Cells and Sensitizes SW480 Cells to the SN38 Chemotherapeutic Agent.
Scagliarini A; Mathey A; Aires V; Delmas D
Cells; 2020 Apr; 9(4):. PubMed ID: 32290112
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thioredoxin-1 enhances the toxicity of glycolysis inhibitor 2-deoxyglucose by downregulating SLC1A5 expression in colorectal cancer cells.
Tang T; Fang D; Ji Z; Zhong Z; Zhou B; Ye L; Jiang L; Sun X
Cell Oncol (Dordr); 2024 Apr; 47(2):607-621. PubMed ID: 37867183
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of FexMoyS-PEG nanoparticles in colorectal cancer: a multimodal approach via ROS-ferroptosis-glycolysis regulation.
Yu Z; Wang C; Ye Y; Wang S; Jiang K
J Nanobiotechnology; 2024 May; 22(1):253. PubMed ID: 38755600
[TBL] [Abstract][Full Text] [Related]
6. Bergenin Inhibits Tumor Growth and Overcomes Radioresistance by Targeting Aerobic Glycolysis.
Li X; Xie L; Zhou L; Gan Y; Han S; Zhou Y; Qing X; Li W
Am J Chin Med; 2023; 51(7):1905-1925. PubMed ID: 37646142
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models.
Palanisamy R; Indrajith Kahingalage N; Archibald D; Casari I; Falasca M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397018
[TBL] [Abstract][Full Text] [Related]
8. Role of endoplasmic reticulum stress in apoptosis induced by HK2 inhibitor and its potential as a new drug combination strategy.
Zhong J; Lu S; Jia X; Li Q; Liu L; Xie P; Wang G; Lu M; Gao W; Zhao T; Wang Q; Su W; Li N
Cell Stress Chaperones; 2022 May; 27(3):273-283. PubMed ID: 35355227
[TBL] [Abstract][Full Text] [Related]
9. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.
Zhang L; Jiang C; Zhong Y; Sun K; Jing H; Song J; Xie J; Zhou Y; Tian M; Zhang C; Sun X; Wang S; Cheng X; Zhang Y; Wei W; Li X; Fu B; Feng P; Wu B; Shu HB; Zhang J
Nat Cell Biol; 2023 Aug; 25(8):1208-1222. PubMed ID: 37443289
[TBL] [Abstract][Full Text] [Related]
10. Retracted Article: Daphnetin inhibits proliferation and glycolysis in colorectal cancer cells by regulating the PI3K/Akt signaling pathway.
He Z; Dong W; Yao K; Qin C; Duan B
RSC Adv; 2018 Oct; 8(60):34483-34490. PubMed ID: 35548643
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Effect and Gut Microbiota Modulation by Quercetin, Luteolin, and Xanthohumol in a Rat Model for Colorectal Cancer Prevention.
Pérez-Valero Á; Magadán-Corpas P; Ye S; Serna-Diestro J; Sordon S; Huszcza E; Popłoński J; Villar CJ; Lombó F
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674851
[TBL] [Abstract][Full Text] [Related]
12. An Association Map on the Effect of Flavonoids on the Signaling Pathways in Colorectal Cancer.
Koosha S; Alshawsh MA; Looi CY; Seyedan A; Mohamed Z
Int J Med Sci; 2016; 13(5):374-85. PubMed ID: 27226778
[TBL] [Abstract][Full Text] [Related]
13. Erianin promotes apoptosis and inhibits Akt-mediated aerobic glycolysis of cancer cells.
Han S; Chen S; Wang J; Huang S; Xiao Y; Deng G
J Cancer; 2024; 15(8):2380-2390. PubMed ID: 38495480
[TBL] [Abstract][Full Text] [Related]
14. Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.
Langley BO; Ryan JJ; Hanes D; Phipps J; Stack E; Metz TO; Stevens JF; Bradley R
Mol Nutr Food Res; 2021 Apr; 65(8):e2001170. PubMed ID: 33629812
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
[TBL] [Abstract][Full Text] [Related]
16. Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis.
Yuan J; Peng G; Xiao G; Yang Z; Huang J; Liu Q; Yang Z; Liu D
J Cancer; 2020; 11(14):4047-4058. PubMed ID: 32368287
[TBL] [Abstract][Full Text] [Related]
17. Xanthohumol targets the ERK1/2‑Fra1 signaling axis to reduce cyclin D1 expression and inhibit non‑small cell lung cancer.
Gao F; Li M; Zhou L; Liu W; Zuo H; Li W
Oncol Rep; 2020 Oct; 44(4):1365-1374. PubMed ID: 32945473
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol protects against Azoxymethane-induced colorectal cancer in Sprague-Dawley rats.
Liu H; Zhang L; Li G; Gao Z
Environ Toxicol; 2020 Feb; 35(2):136-144. PubMed ID: 31714664
[TBL] [Abstract][Full Text] [Related]
19. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]